Private equity consortium increases offer for Biomet to $11.4bn

0
22

The board of directors of Warsaw, Indiana-headquartered Biomet, a specialist in the orthopedic and musculoskeletal product industry, has unanimously recommended to shareholders an increased offer from a private equity consortium including The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG to acquire Biomet for $46 per share in cash, or an equity value of $11.4bn.

The board of directors of Warsaw, Indiana-headquartered Biomet, a specialist in the orthopedic and musculoskeletal product industry, has unanimously recommended to shareholders an increased offer from a private equity consortium including The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG to acquire Biomet for $46 per share in cash, or an equity value of $11.4bn.